Article
Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 Jul 2013
Payne Daniel C, Boom Julie A, Staat Mary Allen, Edwards Kathryn M, Szilagyi Peter G, Klein Eileen J, Selvarangan Rangaraj, Azimi Parvin H, Harrison Christopher, Moffatt Mary, Johnston Samantha H, Sahni Leila C, Baker Carol J, Rench Marcia A, Donauer Stephanie, McNeal Monica, Chappell James, Weinberg Geoffrey A, Tasslimi Azadeh, Tate Jacqueline E, Wikswo Mary, Curns Aaron T, Sulemana Iddrisu, Mijatovic-Rustempasic Slavica, Esona Mathew D, Bowen Michael D, Gentsch Jon R, Parashar Umesh D
Abstract excerpt
BACKGROUND: We assessed vaccine effectiveness (VE) for RotaTeq (RV5; 3 doses) and Rotarix (RV1; 2 doses) at reducing rotavirus acute gastroenteritis (AGE) inpatient and emergency department (ED) visits in US children. METHODS: We enrolled children <5 years of age hospitalized or visiting the ED with AGE symptoms from November 2009-June 2010 and from November 2010-June 2011 at 7 medical institutions. Fecal...
Topics
Join the communities discussing this publication.